Spinal muscular atrophy is caused by mutations in the SMN1 gene, the product of which is part of a multicomponent complex involved in the assembly of small nuclear ribonucleoproteins. A recent study indicates that SMN may also play a role in pre-mRNA splicing.
The tissue-specific phenotype observed in spinal muscular atrophy has, somewhat surprisingly, turned out to be caused by a defect in a general cellular functionthe assembly of small nuclear ribonucleoproteins (snRNPs) (reviewed in [4] ). Dreyfuss and colleagues [5] have now found that when a mutant form of SMN is expressed in cultured cells, it causes a dramatic reorganization of snRNPs in both the nucleus and the cytoplasm. Furthermore, the mutant protein has a dominant-negative effect on pre-mRNA splicing in vitro, suggesting that SMN also plays an important role in the function, as well as the biogenesis, of snRNPs.
The SMN loci
There are actually two closely related SMN genes, located within a 500 kilobase inverted duplication on human chromosome 5q13 [3] . Deletion of the telomeric copy, SMN1, results in the disease, whereas similar mutations in the centromeric copy, SMN2, have no detectable phenotypic effects [6] . So although their coding regions differ by only five silent sequence changes, the SMN genes appear not to be functionally redundant ( [7] and references therein). Notably, there is only one equivalent gene in the mouse genome, and it is essential: a targeted deletion of the Smn gene results in embryonic lethality in the homozygous state [8] . As reviewed last year in these pages [4] , the SMN protein has been found to be part of a large (~300 kDa) complex of proteins that are involved in the biogenesis of snRNPs [9, 10] . These include 'SMN interacting proteins' (SIP1, SIP2 and SIP3) as well as snRNP core components, collectively called Sm proteins (B, D1-3 and E-G) [9] . Moreover, antibodies against SIP1 inhibit the assembly and nuclear import of spliceosomal snRNPs [10] .
In most cell types, SMN protein is distributed diffusely throughout the cytoplasm (Figure 1 ), whereas the nuclear fraction is localised within discrete foci [11] . These nuclear foci are found adjacent to, or merged with, nuclear organelles called coiled bodies, and they have thus been termed 'gemini of coiled bodies' or 'gems' (reviewed in [12] ). Coiled bodies are characterized by the presence of a marker protein called p80 coilin, and contain extremely high concentrations of snRNPs (reviewed in [13] ). The initial phases of snRNP assembly take place in the cytoplasm and are mediated by the SMN complex ( [10] and references therein). This complex may then accompany the assembled snRNPs on their journey to nuclear gems and coiled bodies. Until recently, however, a functional role for SMN within the nucleus has not been demonstrated.
A dominant-negative SMN mutation
Although SMN mutations that give rise to spinal muscular atrophy are recessive, Dreyfuss and colleagues [5] have now shown that the expression in cultured cells of a mutant form of SMN with an amino-terminal deletion, called SMN∆N27, causes a profound reorganization of splicing snRNPs in the nucleoplasm. This dominantnegative phenotype is similar to those caused by inhibition of pre-mRNA splicing [14] or RNA polymerase II transcription [15] , and involves a dramatic enlargement of nuclear structures that contain splicing snRNPs. In the latter two cases, the swollen structures correspond to interchromatin granule clusters, commonly called 'speckles'. In contrast, the structures undergoing enlargement in the presence of the SMN∆N27 mutant are apparently not speckles, because they do not stain with anti-SR protein epitopes such as SC-35 (G. Dreyfuss, personal communication). Rather, they appear to be related to coiled bodies and gems, as typical components such as p80 coilin, SMN, SIP1, U2 snRNA and Sm proteins are all enriched within the large structures [5] .
Interestingly, SMN∆N27 also causes a reorganization of the cytoplasmic fraction of the SMN and snRNP staining patterns. Instead of the normal, diffuse localisation of SMN throughout the cytoplasm, cells expressing SMN∆N27 display a number of punctate blobs in the cytoplasm. Most striking is the fact that the cytoplasmic blobs result from an apparent block in cytoplasmic snRNP assembly, as they contain U2 snRNA and Sm proteins, but their snRNAs lack a trimethylguanosine cap. So although snRNAs within the nuclei of the transfected cells are trimethylated, those trapped within the cytoplasmic structures appear to be partially assembled, and are presumably arrested at a step preceding cap hypermethylation [5] . But if SMN∆N27 affects only cytoplasmic snRNP assembly, why are there large structures in the nucleus?
SMN and splicing
Dreyfuss and colleagues [5] reasoned that because SMN∆N27 causes such a large-scale reorganization of splicing factors in the nucleus, it might also have dominant effects on pre-mRNA splicing in vitro. Nonetheless, initial attempts to demonstrate splicing inhibition met with frustration, as addition of purified SMN∆N27 protein to in vitro extracts had no effect; further 'order-of-addition' experiments, however, did reveal an effect on splicing. When SMN∆N27 protein or antibodies against the SMN amino terminus were present during pre-incubation of a splicing extract with an ATP regenerating system, before addition of the labeled pre-mRNA substrate, splicing was completely inhibited [5] . The block to splicing occurred prior to the first step, as no partially-spliced intermediates were detected. Control reactions using wild-type SMN or antibodies against the protein's carboxyl terminus did not inhibit, and in some cases actually stimulated, splicing. These results suggest that SMN, and by inference the machinery within coiled bodies and gems, participates in nuclear snRNP function. Dreyfuss and colleagues [5] went on to test this idea by looking at spliceosomal complexes formed in the splicing extract using native gel electrophoresis. They found that pre-incubation of the extract in the absence of added SMN protein resulted in a decreased ability to form higher-order snRNP complexes in the presence of ATP. When extracts were supplemented with a 3-5-fold molar excess of recombinant wild-type SMN protein, the ability to make these complexes was restored. Pre-incubation with SMN∆N27 protein apparently allowed formation of the pre-catalytic A and B complexes, but not catalytically active spliceosomes (C complexes). Thus, in vitro, SMN is a limiting reagent in the formation of higher-order complexes, and its amino terminus appears to be somehow involved in the transition from pre-catalytic to catalytically active spliceosomes. Dreyfuss and colleagues [5] posit that SMN∆N27 produces complexes that are trapped in a nonfunctional state, and that wild-type SMN may participate in regeneration of 'used' splicing factors.
While the above scenario may certainly be correct, the data are consistent with a number of alternative hypotheses. For example, it is possible that SMN protein may not actually function in splicing in vivo -it may simply contain motifs present in bona fide spliceosome components, and when SMN is overexpressed in vitro these shared motifs result in displacement of the related proteins or sequestration of their binding partners. Interestingly, database analysis reveals the existence of a putative SMN-related splicing factor: SPF-30, a protein identified as part of a large-scale characterization of spliceosomal proteins [16] , has a region of significant similarity to SMN, in addition to a number of highly conserved residues throughout the length of the protein. Additional experiments will be required in order to exclude this and other possibilities, and improve our understanding of the nature of the dominant-negative effect of SMN∆N27.
Although the precise function of the amino-terminal region of SMN is unclear, it is perhaps noteworthy that regions of the protein that interact with SIP1 and SmB [9] are not affected by the 27 amino-acid truncation in SMN∆N27. Curiously, wild-type Xenopus SMN protein has the same dominant-negative effect when expressed in human cells (G. Dreyfuss, personal communication), and alignment of the human and frog proteins reveals that the Dispatch R141
Figure 1
In HeLa cells, SMN protein is localized throughout the cytoplasm but present in several bright foci within each nucleus. The protein was revealed by staining with monoclonal antibody 2B1 (gift of G. Dreyfuss); the cells were permeabilized with Triton-X 100 after fixation in paraformaldehyde. The bright nuclear foci are completely coincident with p80 coilin staining (see [12] for discussion). Overexpression of the mutant form SMN∆N27 causes these structures to become greatly enlarged -to nearly the same size as nucleoli -and has dominantnegative effects on pre-mRNA splicing in vitro [5] .
R142 Current Biology, Vol 9 No 4 frog protein lacks these amino-terminal residues. These observations suggest that the amino terminus of human SMN is required for some event, perhaps a conformational change, that is necessary for the production of active spliceosomes. Thus, while the multi-snRNP complexes that form in the presence of SMN∆N27 may migrate on gels at a position similar to intact spliceosomes, they may actually be 'dead-end' complexes, unable to participate in splicing or serve as substrates for disassembly.
As with most provocative research endeavours, the results reported by Dreyfuss and colleagues [5] actually generate more questions than they answer. Future research on the roles of SMN protein, gems and coiled bodies in the biogenesis and functions of small RNPs should bring new insights into the cell biology of the nucleus, especially the metabolic processes that take place within the various subdomains and their relevance to the treatment of molecular diseases such as spinal muscular atrophy.
